Form 4: Waystar CFO Steven Oreskovich Executes Stock Options and Sells Shares

Waystar Holding Corp.'s Chief Financial Officer, Steven M. Oreskovich, exercised stock options and sold a portion of his holdings on March 12, 2025, according to a recent SEC filing.

Summary

• On March 12, 2025, Steven M. Oreskovich, the Chief Financial Officer of Waystar Holding Corp., exercised stock options to acquire 16,666 shares of common stock at a price of $4.14 per share.
• Following the exercise of these options, Oreskovich sold 15,966 shares at a weighted average price of $36.9969, with individual transactions ranging from $36.70 to $37.66.
• He also sold 700 shares at a weighted average price of $38.0729, with individual transactions ranging from $37.74 to $38.37.
• After these transactions, Oreskovich beneficially owns 173,642 shares of Waystar Holding Corp. common stock.
• The transactions were executed automatically pursuant to a pre-arranged trading plan adopted on September 6, 2024, under Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: Neutral sentiment. The transactions appear to be part of a pre-planned strategy and don't necessarily indicate a change in the executive's confidence in the company.

Positives

• The transactions were executed under a pre-arranged trading plan, suggesting they were planned well in advance and not based on immediate insider information.

Risks

• While the transactions were pre-planned, significant sales by a company executive could be perceived negatively by some investors.

Industry Context

Insider transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects. However, pre-planned sales under Rule 10b5-1 plans are less indicative of immediate sentiment.

Comparison to Industry Standards

• It's common for executives at publicly traded companies like Waystar to have stock option grants as part of their compensation packages.
• The exercise and sale of these options are often governed by pre-arranged trading plans to avoid accusations of insider trading, similar to the Rule 10b5-1 plan used by Mr. Oreskovich.
• Comparable companies such as Veeva Systems or Cerner (now Oracle Health) also see regular Form 4 filings from their executives related to stock transactions.

Stakeholder Impact

• The sale of shares by a high-ranking executive could create short-term uncertainty among shareholders.
• However, the pre-planned nature of the transactions may mitigate concerns.

Key Dates